N-(4-Bromo-2-methylphenyl)-2-(pyridin-2-ylsulfanyl)acetamide

Catalog No. :
ACZPYO325
CAS No. :
329078-56-0
Molecular Formula :
C14H13BrN2OS
Molecular Weight :
337.24

IUPAC Name:N-(4-bromo-2-methylphenyl)-2-(pyridin-2-ylthio)acetamide

N-(4-Bromo-2-methylphenyl)-2-(pyridin-2-ylsulfanyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Bromo-2-methylphenyl)-2-(pyridin-2-ylsulfanyl)acetamide
IUPAC NameN-(4-bromo-2-methylphenyl)-2-(pyridin-2-ylthio)acetamide
MDL No.MFCD00169104
Molecular FormulaC14H13BrN2OS
Molecular Weight337.24
SMILESO=C(NC1=CC=C(Br)C=C1C)CSC2=NC=CC=C2
InChI KeyXMODUOGKYGQEBL-UHFFFAOYSA-N
SynonymN-(4-BROMO-2-METHYLPHENYL)-2-(2-PYRIDINYLSULFANYL)ACETAMIDE;N-(4-bromo-2-methylphenyl)-2-(pyridin-2-ylsulfanyl)acetamide;Acetamide, N-(4-bromo-2-methylphenyl)-2-(2-pyridinylthio)-
CAS No.329078-56-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZPYO325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACATZC048 route compound structure diagram
    ACATZC048583-75-5 In Stock
  2. Plus
  3. ACHDNK468 route compound structure diagram
    ACHDNK46810002-29-6 In Stock
  4. Then
  5. ACZPYO325 route product structure diagram
    ACZPYO325329078-56-0
Inquiry

2. ACZPYO325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXEBQ761 route compound structure diagram
    ACXEBQ76196686-51-0 In Stock
  2. Plus
  3. ACVMGT218 route compound structure diagram
    ACVMGT2182637-34-5 In Stock
  4. Then
  5. ACZPYO325 route product structure diagram
    ACZPYO325329078-56-0
Inquiry

Comments (0)